share_log

三葉草生物-B：截至2024年1月31日止月份股份發行人的證券變動月報表

CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended January 31, 2024

香港交易所 ·  Feb 1 21:51
Summary by Moomoo AI
三葉草生物製藥有限公司（「三叶草生物-B」）於2024年2月2日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年1月31日的股份變動情況。報告顯示，公司的法定/註冊股本及已發行股份在本月內均無變動，維持在2,000,000,000股，每股面值0.0001美元，總額200,000美元。然而，在股份期權方面，根據首次公開發售前後的購股權計劃，本月內有股份期權被行使，導致653,196新股份的發行，並收取了相應的資金總額5,225.56港元。該公司確認所有新發行的證券均已獲得董事會的正式授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
三葉草生物製藥有限公司（「三叶草生物-B」）於2024年2月2日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年1月31日的股份變動情況。報告顯示，公司的法定/註冊股本及已發行股份在本月內均無變動，維持在2,000,000,000股，每股面值0.0001美元，總額200,000美元。然而，在股份期權方面，根據首次公開發售前後的購股權計劃，本月內有股份期權被行使，導致653,196新股份的發行，並收取了相應的資金總額5,225.56港元。該公司確認所有新發行的證券均已獲得董事會的正式授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
Clover Biopharmaceuticals Limited (“Shamus Bio-B”) filed with Hong Kong Trading and Settlement Limited on February 2, 2024 an updated Monthly Statement of Changes in Securities Reporting for the year ended January 31, 2024. The report shows that the company's regulated/registered share capital and issued shares remained unchanged during the month at 2,000,000,000 shares with a face value of $0.0001 per share for a total of $200,000. However, in the area of share options, under the Initial Public Offering (IPO), share options were exercised this month, resulting in the issuance of 653,196 new shares and a corresponding sum of HK$5,225.56. The Company confirms that all newly issued securities have been formally authorized by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Clover Biopharmaceuticals Limited (“Shamus Bio-B”) filed with Hong Kong Trading and Settlement Limited on February 2, 2024 an updated Monthly Statement of Changes in Securities Reporting for the year ended January 31, 2024. The report shows that the company's regulated/registered share capital and issued shares remained unchanged during the month at 2,000,000,000 shares with a face value of $0.0001 per share for a total of $200,000. However, in the area of share options, under the Initial Public Offering (IPO), share options were exercised this month, resulting in the issuance of 653,196 new shares and a corresponding sum of HK$5,225.56. The Company confirms that all newly issued securities have been formally authorized by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more